Análisis
Análisis en profundidad de mercados farmacéuticos, cadenas de suministro, tecnología y regulación
#US market entry ×
Análisis
1 sept 2026•1 min de lectura
HK Innoen's K‑Cap (Tegoprazan) Targets US Launch, Boosts Growth Prospects
Domestic drug K‑Cap (tegoprazan) is nearing US market entry, with analysts seeing royalty revenue and a shift to global growth for HK Innoen.
Análisis
30 ago 2026•1 min de lectura
WiseBuzz Forms US DTC Advertising Team to Support Korean Pharma Expansion
WiseBuzz announced the creation of a dedicated US Direct‑to‑Consumer advertising team to help Korean pharma and biotech firms launch DTC campaigns in the United States.